LensGen®, Inc. has closed a $21 million Series A financing to advance the development of its lead product, Juvene™ — reportedly the world’s first modular, fluid-optic accommodating intraocular lens (IOL).
The financing was reportedly led by the corporate venture investment arm of HOYA Group and included participation from Relativity Healthcare Partners. The financing includes an option to expand the financing commitment by an additional $5 million.
According to LensGen, the Juvene IOL is designed with the potential to permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia. The lens — which is implanted using current surgical techniques used for traditional IOLs — reportedly provides accommodation by mimicking the eye’s natural accommodation process to change shape and adjust focus, like the autofocus of a camera.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.